Internal Medicine

A-HeFT

Study

AATAC

Study

Abaloparatide

Drug

Abatacept for IIM

Study

ABYSS

Study

Acarbose

Drug

ACCOMPLISH

Study

ACCORD

Study

ACCORD BP

Study

ACCORD Lipid

Study

ACE-PROTAVI

Study

Acebutolol

Drug

ACORN

Study

Acromegaly

Disease

Acromegaly — Perioperative management

Pathway

ACT

Study

ACT HIV

Study

ACTIVE A

Study

ACTIVE W

Study

Acute bacterial meningitis

Disease

Acute diarrhea

Disease

Acute hepatic porphyria

Disease

Acute interstitial nephritis

Disease

Acute ischemic stroke

Disease

Acute kidney injury

Disease

Acute limb ischemia

Disease

Acute pain

Disease

Acute pancreatitis

Disease

Acute pericarditis

Disease

Acute pyelonephritis

Disease

Acyclovir

Drug

ADAPT

Study

ADAPT-PO

Study

ADAPT-TAVR

Study

ADH-Wizard

Study

Adhesive capsulitis

Disease

Adhesive capsulitis — Diagnosis and management

Pathway

ADMINISTER

Study

Adrenal incidentaloma

Disease

Adrenocortical carcinoma

Disease

Adult growth hormone deficiency

Disease

Adult-onset Still's disease

Disease

ADVANCE (intensive glucose control)

Study

ADVANCE-CIDP 1

Study

ADVOCATE

Study

ADVOR

Study

AECOPD

Study

AF-CHF

Study

AFFINITY

Study

AFFIRM

Study

AGENT IDE

Study

AHA STEROID

Study

AID-ICU

Study

AIDA

Study

AiDAPT

Study

AIRFLO

Study

AIRTRIP

Study

AKIKI

Study

Alanine aminotransferase, increased

Finding

Albumin for CSA-AKI

Study

Albumin for SBP

Study

Alcohol-related liver disease

Disease

ALIGN

Study

Alirocumab

Drug

Aliskiren

Drug

ALL-HEART

Study

Allergic bronchopulmonary aspergillosis

Disease

ALLHAT (angiotensin-converting enzyme inhibitor)

Study

ALLHAT (calcium channel blocker)

Study

ALLIUM

Study

Allopurinol

Drug

ALMS

Study

Alternate day vs. daily oral iron in IDA

Study

ALTITUDE

Study

Altshock-2

Study

AMACING

Study

AMAZES

Study

AMBITION-CM

Study

AMETIS

Study

Amiodarone

Drug

Amlodipine

Drug

AMPLIFY (apixaban)

Study

AMPLIFY-EXT (apixaban 2.5 mg)

Study

AMPLIFY-EXT (apixaban 5 mg)

Study

Amyotrophic lateral sclerosis

Disease

ANAHYDRET

Study

ANCHOR

Study

ANDROMEDA

Study

Anemia of chronic kidney disease

Disease

ANGEL-ASPECT

Study

ANRS 174 DOXYVAC (doxycycline PEP)

Study

ANRS IPERGAY

Study

ANSWER

Study

Anti-glomerular basement membrane disease

Disease

AntibioCor

Study

Antidromic atrioventricular reentrant tachycardia

Disease

Antimicrobial-resistant Gram-negative infections

Disease

Antiphospholipid syndrome

Disease

Antiphospholipid syndrome — Investigation

Pathway

Aortic regurgitation

Disease

Aortic stenosis

Disease

APEX

Study

API-CAT

Study

Apixaban

Drug

Aplastic anemia

Disease

APPLAUSE-IgAN

Study

Aprocitentan

Drug

ARAIS

Study

ARAMIS

Study

ARCADIA (original research)

Study

ARCADIA (post-hoc analysis)

Study

ARCADIA-MRI

Study

ARES (aspirin BID vs. aspirin OD)

Study

ARES (aspirin TID vs. aspirin OD)

Study

ARIES-HM3 (original research)

Study

ARIES-HM3 (secondary analysis)

Study

ARISTOTLE

Study

ARIVA

Study

ARRECTOR

Study

Arrhythmogenic right ventricular cardiomyopathy

Disease

ARRIVE (aspirin)

Study

ARTESIA

Study

ASCEND (aspirin)

Study

ASCEND (pirfenidone)

Study

ASCEND-D

Study

Ascites

Disease

ASPEN (brensocatib 10 mg)

Study

ASPEN (brensocatib 25 mg)

Study

ASPIRE

Study

ASPRE

Study

ASPREE

Study

ASPREE (secondary analysis)

Study

ASSIT

Study

Asthma

Disease

ASTRAL

Study

ATAMIS

Study

Atenolol

Drug

ATLAS (cabotegravir and rilpivirine)

Study

ATLAS ACS 2-TIMI 51 (rivaroxaban 10 mg)

Study

ATLAS ACS 2-TIMI 51 (rivaroxaban 5 mg)

Study

ATLAS-2M (152-week results)

Study

ATLAS-2M (48-week results)

Study

ATN

Study

Atorvastatin

Drug

Atrasentan

Drug

Atrial fibrillation

Disease

Atrial flutter

Disease

Atrioventricular nodal reentrant tachycardia

Disease

ATTENTION-IA

Study

ATTIRE

Study

ATTR-ACT

Study

ATTRACT

Study

ATTRibute-CM

Study

Atypical hemolytic uremic syndrome

Disease

AUGUSTUS (anticoagulation regimen)

Study

AUGUSTUS (antiplatelet regimen)

Study

AURORA (rosuvastatin)

Study

AURORA 2

Study

AUSTRI

Study

Autoimmune hemolytic anemia

Disease

Autoimmune hepatitis

Disease

Autoimmune pancreatitis

Disease

Autoimmune pancreatitis — Management

Pathway

Autosomal dominant polycystic kidney disease

Disease

AVATAR

Study

AVB-TIPS

Study

AVERROES

Study

AVERT

Study

AVERT (subgroup analysis)

Study

AVOID

Study

AWARE

Study

Axatilimab

Drug

Axial spondyloarthritis

Disease

AZA-001

Study

AZALEA-TIMI 71 (high-dose abelacimab)

Study

AZALEA-TIMI 71 (low-dose abelacimab)

Study

Azathioprine

Drug

Azilsartan

Drug

Azilsartan / chlorthalidone

Drug

AZT Trial

Study

Aztreonam

Drug

Aztreonam / avibactam

Drug